Goldman Sachs’s NexImmune, Inc. Common Stock NEXI Stock Holding History
Bought
Maintained
Sold
Other funds holding NEXI
SPC
AO
ECG
RJA
Goldman Sachs's NEXI Position: Q1 2023 in Review
Goldman Sachs sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2023, closing a stake of 37,038 shares — an estimated $225K sold.
Goldman Sachs first reported a position in NEXI in Q2 2022 and held it in 2 quarters. The position peaked at $225K in Q4 2022. 31 funds tracked by Wall St. Rank hold NEXI as of Q1 2023.
- Goldman Sachs reported no remaining NexImmune, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Goldman Sachs sold 37,038 NexImmune, Inc. Common Stock shares in Q1 2023, an estimated $225K.
- Goldman Sachs first reported a position in NexImmune, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
- Goldman Sachs's NexImmune, Inc. Common Stock position peaked at $225K in Q4 2022.
- 31 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2023.
Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.